16D0 Dalakas, Marinos - Thomas Jefferson University - Thomas Jefferson University

Marinos C. Dalakas, MD, FAAN

Contact Dr. Dalakas

901 Walnut Street
4th Floor
Philadelphia, PA 19107

(215) 955 -7865
(215) 955-9976 fax

Most Recent Peer-reviewed Publications

  1. Pathogenesis of immune-mediated neuropathies
  2. Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders
  3. Lower extremity peak force and gait kinematics in individuals with inclusion body myositis
  4. Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders
  5. Reliability of the adult myopathy assessment tool in individuals with myositis
  6. Intravenous immunoglobulin in neurology-mode of action and clinical efficacy
  7. Immunotherapy-responsive limbic encephalitis with antibodies to glutamic acid decarboxylase
  8. Pathogenesis of immune-mediated neuropathies
  9. IVIg in the chronic management of myasthenia gravis: Is it enough for your money?
  10. 7th International immunoglobulin conference: Interlaken leadership awards
  11. Mechanistic effects of IVIg in neuroinflammatory diseases: Conclusions based on clinicopathologic correlations
  12. 7th International Immunoglobulin Conference: Interlaken Leadership Awards
  13. Reduction of Intraepidermal Nerve Fiber Density (IENFD) in the skin biopsies of patients with fibromyalgia: A controlled study
  14. Are repeated single-limb heel raises and manual muscle testing associated with peak plantar-flexor force in people with inclusion body myositis?
  15. Validity of the single limb heel raise test to predict lower extremity disablement in patients with sporadic inclusion body myositis
  16. Glycine receptor antibodies in stiff-person syndrome and other GAD-positive CNS disorders.
  17. The effect of anakinra, an IL1 receptor antagonist, in patients with sporadic inclusion body myositis (sIBM): A small pilot study
  18. Inclusion body myositis: from immunopathology and degenerative mechanisms to treatment perspectives
  19. Immunology of stiff person syndrome and other GAD-associated neurological disorders
  20. Progress and stiff challenges in understanding the role of GAD-antibodies in stiff-person syndrome